These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15928832)

  • 21. Phenyl-oxazoles, a new family of inverse agonists at the H(3) histamine receptor.
    Denonne F; Atienzar F; Célanire S; Christophe B; Delannois F; Delaunoy C; Delporte ML; Durieu V; Gillard M; Lallemand B; Lamberty Y; Lorent G; Vanbellinghen A; Van Houtvin N; Verbois V; Provins L
    ChemMedChem; 2010 Feb; 5(2):206-12. PubMed ID: 20043314
    [No Abstract]   [Full Text] [Related]  

  • 22. Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.
    Morini G; Comini M; Rivara M; Rivara S; Lorenzi S; Bordi F; Mor M; Flammini L; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
    Bioorg Med Chem Lett; 2006 Aug; 16(15):4063-7. PubMed ID: 16713264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a homology model of the human histamine H(3) receptor for ligand docking and pharmacophore-based screening.
    Schlegel B; Laggner C; Meier R; Langer T; Schnell D; Seifert R; Stark H; Höltje HD; Sippl W
    J Comput Aided Mol Des; 2007 Aug; 21(8):437-53. PubMed ID: 17668276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel potent (dihydro)benzofuranyl piperazines as human histamine receptor ligands - Functional characterization and modeling studies on H
    Corrêa MF; Balico-Silva AL; Kiss DJ; Fernandes GAB; Maraschin JC; Parreiras-E-Silva LT; Varela MT; Simões SC; Bouvier M; Keserű GM; Costa-Neto CM; Fernandes JPS
    Bioorg Med Chem; 2021 Jan; 30():115924. PubMed ID: 33333448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine.
    Ali SM; Tedford CE; Gregory R; Yates SL; Phillips JG
    Bioorg Med Chem Lett; 1998 May; 8(10):1133-8. PubMed ID: 9871722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new family of histamine H3 receptor antagonists based on a natural product: discovery, SAR, and properties of the series.
    Cowart M; Sun M; Zhao C; Witte DG; Miller TR; Krueger KM; Browman K; Fox GB; Bennani YL; Esbenshade TA; Hancock AA
    Inflamm Res; 2007 Apr; 56 Suppl 1():S47-8. PubMed ID: 17806176
    [No Abstract]   [Full Text] [Related]  

  • 27. Probing the importance of N-glycosylation for [(3)H] clobenpropit binding to human H (3) receptors expressed in HEK 293 cells . 3. Molecular and chemical aspects of the histamine receptors.
    Shenton FC; Chazot PL
    Inflamm Res; 2006 Apr; 55 Suppl 1():S40-1. PubMed ID: 16547815
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H
    Corrêa MF; Barbosa ÁJR; Fernandes GAB; Baker JG; Fernandes JPDS
    Chem Biol Drug Des; 2019 Jan; 93(1):89-95. PubMed ID: 30153371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists.
    Stark H; Kathmann M; Schlicker E; Schunack W; Schlegel B; Sippl W
    Mini Rev Med Chem; 2004 Nov; 4(9):965-77. PubMed ID: 15544557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, biological evaluation, and molecular docking of novel flavones as H
    Wen G; Liu Q; Hu H; Wang D; Wu S
    Chem Biol Drug Des; 2017 Oct; 90(4):580-589. PubMed ID: 28328173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guided rational design with scaffold hopping leading to novel histamine H
    Ghamari N; Kouhi Hargelan S; Zivkovic A; Leitzbach L; Dastmalchi S; Stark H; Hamzeh-Mivehroud M
    Bioorg Chem; 2021 Dec; 117():105411. PubMed ID: 34653944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine.
    Aslanian R; Mutahi Mw; Shih NY; Piwinski JJ; West R; Williams SM; She S; Wu RL; Hey JA
    Bioorg Med Chem Lett; 2003 Jun; 13(12):1959-61. PubMed ID: 12781173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity.
    Covel JA; Santora VJ; Smith JM; Hayashi R; Gallardo C; Weinhouse MI; Ibarra JB; Schultz JA; Park DM; Estrada SA; Hofilena BJ; Pulley MD; Smith BM; Ren A; Suarez M; Frazer J; Edwards J; Hauser EK; Lorea J; Semple G; Grottick AJ
    J Med Chem; 2009 Sep; 52(18):5603-11. PubMed ID: 19722526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists.
    Gfesser GA; Zhang H; Dinges J; Fox GB; Pan JB; Esbenshade TA; Yao BB; Witte D; Miller TR; Kang CH; Krueger KM; Bennani YL; Hancock AA; Faghih R
    Bioorg Med Chem Lett; 2004 Feb; 14(3):673-6. PubMed ID: 14741266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor.
    Peschke B; Bak S; Hohlweg R; Nielsen R; Viuff D; Rimvall K
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3162-5. PubMed ID: 16616493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
    Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
    J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different antagonist binding properties of human and rat histamine H3 receptors.
    Stark H; Sippl W; Ligneau X; Arrang JM; Ganellin CR; Schwartz JC; Schunack W
    Bioorg Med Chem Lett; 2001 Apr; 11(7):951-4. PubMed ID: 11294398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorinated non-imidazole histamine H3 receptor antagonists.
    Isensee K; Amon M; Garlapati A; Ligneau X; Camelin JC; Capet M; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2172-5. PubMed ID: 19286376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.
    Faghih R; Dwight W; Black L; Liu H; Gentles R; Phelan K; Esbenshade TA; Ireland L; Miller TR; Kang CH; Krueger KM; Fox GB; Hancock AA; Bennani YL
    Bioorg Med Chem Lett; 2002 Aug; 12(15):2035-7. PubMed ID: 12113836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.